Bleeding Disorders
From the Journals
Combined exercise training shows benefit in hemophilia A
Combining aerobic and resistance training appears to be the best approach for reducing proinflammatory markers in this population of patients.
From the Journals
Past donor pregnancy, sex do not affect transfusion-related mortality
A retrospective analysis of more than 1 million red blood cell transfusion recipients found that there was no significant increase in mortality...
News
FDA: Faulty hematology analyzers face class I recall
Beckman Coulter has released a software patch it hopes may help warn operators of inaccurate results, but this fix has not been evaluated by the...
From the Journals
FVIII/W ratio may help predict relapse in hemophilia A
The biological marker was the first indication of relapse in most patients who relapsed during the study period.
From the Journals
Novel chromogenic assay looks accurate in hemophilia A diagnosis
The BIOPHEN FVIII:C assay had limited variation and performed well when compared with a one-stage clotting assay and another chromogenic assay,...
From the Journals
Low-dose FVIII prophylaxis reduced bleeding in hemophilia A
Low-dose prophylaxis with factor VIII outperformed on-demand treatment in children with severe hemophilia A. The findings have implications for...
From the Journals
Family history plays a large role in bleeding disorder diagnosis in women
The survey of women with congenital bleeding disorders in Europe highlighted delays in diagnosis and burdens on activities of daily living.
News
Peanut contamination risk prompts Promacta recall
Three lots were affected by potential peanut flour contamination at a third-party manufacturing site.
Conference Coverage
QOL concerns prompt second-line therapy in children with ITP
NEW ORLEANS – Quality of life was the most common reason for starting second-line therapy in a cohort of children with immune thrombocytopenia.
From the Journals
Study finds lower quality of life for patients with hemophilia A
Patients with hemophilia A reported lower health-related quality of life even though they were receiving standard treatment.
From the Journals
New recommendations on immune tolerance induction in hemophilia A
A nine-member expert panel recommended the concurrent use of factor VIII replacement therapy and emicizumab to inhibit bleeding with lower-dose...